We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Uremic Toxins of Patients With Acute Kidney Failure

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00148044
First Posted: September 7, 2005
Last Update Posted: December 28, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Ghent
  Purpose
Determination of the concentration of uremic toxins of sepsis patients with or without acute kidney failure compared to the concentrations of uremic toxins of chronically uremic patients

Condition Intervention
Kidney Failure, Acute Procedure: Blood sampling for determination of uremic toxins

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Uremic Toxins of Patients With Acute Kidney Failure

Further study details as provided by University Hospital, Ghent:

Estimated Enrollment: 30
Study Start Date: October 2003
Study Completion Date: February 2004
Detailed Description:
Determination of the concentration of uremic toxins of sepsis patients with or without acute kidney failure compared to the concentrations of uremic toxins of chronically uremic patients
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Intensive Care patients with sepsis
  • Patients with acute kidney failure: serum creatinin > 2 mg/dl
  • Chronic haemodialysis patients

Exclusion Criteria:

  • < 18 years
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00148044


Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Raymond Vanholder, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00148044     History of Changes
Other Study ID Numbers: 2003/298
First Submitted: September 6, 2005
First Posted: September 7, 2005
Last Update Posted: December 28, 2007
Last Verified: December 2007

Additional relevant MeSH terms:
Renal Insufficiency
Acute Kidney Injury
Kidney Diseases
Urologic Diseases